Bayer/BAYN

€26.12

-0.38%
-
1D1W1MYTD1YMAX

About Bayer

Bayer AG is a German-based life science company. The Company's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on seeds, improved plant traits, chemical and biological crop protection products, digital solutions and customer service for sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others.

Ticker

BAYN

Sector

Healthcare

Trading on

XETRA

Industry

Biotechnology & Drugs

CEO

William Anderson

Employees

99,723

Headquarters

Leverkusen, Germany

Bayer Metrics

BasicAdvanced
€25.79B
Market cap
-
P/E ratio
-€2.99
EPS
1.05
Beta
€0.11
Dividend rate
0.42%
Dividend yield
€25.79B
1.05112
€61.57
€24.96
4.75M
€0.11
1.275
0.801
115.941
136.684
12.839
3.4%
-2.44%
-8.2%
-3.34%
0.541
0.783
10.988
3.73%
0.42%
0.42%
-6.11%
-170.87%
4.79%
-61.97%

Bayer Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
11.27% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
€11.86B
14.7%
Net income
€1.34B
-129.26%
Profit margin
11.27%
-125.52%

Bayer Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 25.68%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
€2.95
€1.22
€0.38
€1.85
-
Expected
€2.88
€1.26
€0.69
€1.47
€2.35
Surprise
2.61%
-3.27%
-45.3%
25.68%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and Deutsche Börse. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Bayer stock?

Bayer (BAYN) has a market cap of €25.79B as of April 18, 2024.

What is the P/E ratio for Bayer stock?

The price to earnings (P/E) ratio for Bayer (BAYN) stock is 0 as of April 18, 2024.

Does Bayer stock pay dividends?

Yes, the Bayer (BAYN) stock pays dividends to shareholders. As of April 18, 2024, the dividend rate is €0.11 and the yield is 0.42%. Bayer has a payout ratio of 0% on a trailing twelve-month basis.

When is the next Bayer dividend payment date?

The next Bayer (BAYN) dividend payment is scheduled for May 02, 2024.

What is the beta indicator for Bayer?

Bayer (BAYN) has a beta rating of 1.05. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Bayer stock price target?

The target price for Bayer (BAYN) stock is €, which is 100% below the current price of €26.12. This is an average based on projections from analyst, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Bayer stock

Buy or sell Bayer stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing